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Summary Enzyme histochemical and immunohistological (immuno-fluorescence and -peroxidase) techniques
have been routinely used for investigating over 70 normal and pathological bone marrow samples. This
recently standardized diagnostic procedure is very quick and can be performed in a few hours. In 6 cases the
clinical diagnosis of leukaemia/lymphoma has become apparent only after the immunohistological analysis of
the bone marrow. In 6 other cases the information about the staging of B cell malignancies was superior in
the frozen biopsies to the paraffin embedded preparations. Amongst many other features the monoclonality
of B CLL/lymphomas, the special features of B CLL infiltrates (RFA-1+, Leu-l+, HLA-DR+, SmIg+),
follicular lymphoma deposits (containing follicular dendritic cells) and non-T, non-B acute lymphoblastic
leukaemic blasts (terminal transferase+, HLA-DR+) as well as the sometimes conspicuous presence of
infiltrating normal T cells could be clearly and reproducibly demonstrated.
The precise identification of neoplastic cells is
important in the assessment of prognosis, and
provides a rationale for selecting the appropriate
therapy. Enzyme histochemistry and immunohisto-
chemistry are now widely used for this purpose, so
that different types of leukaemias and lymphomas
can be readily characterized. A number of enzymes
and immunological markers (mainly cytoplasmic
antigens) can be demonstrated in samples
embedded in paraffin or plastic (Beckstead &
Baiton, 1980; Chilosi et al., 1981; Taylor &
Kledzik, 1981). More information can be obtained
using cryostat sections of frozen samples; most
membrane, cytoplasmic and nuclear antigens are
detectable on this material, and an impressive array
of markers (including those detected by
conventional and monoclonal antibodies) is
available for cell phenotyping (Stein et al., 1980;
Gatter et al., 1982).
This is also the case for bone marrow biopsies
obtained for the diagnosis and staging of a number
of neoplastic conditions, in particular Hodgkin's
and non-Hodgkin's lymphomas (Byrnes et al., 1978;
Burkhardt et al., 1982; Dick et al., 1974; Savage et
al., 1978). In order to evaluate bone marrow
involvement in non-Hodgkin's lymphoma by
immunohistological methods we have recently
developed a procedure for obtaining cryostat
sections of unfixed non-decalcified trephine biopsies
(Chilosi et al., 1982b; Pizzolo et al., 1982). The
sections obtained with this technique are suitable
for detailed immunohistological analysis using a
large panel of antibodies as well as enzyme histo-
chemistry, including enzymes that do not survive
the embedding procedure even when decalcification
is omitted. An immunohistochemical study on bone
marrow cryostat sections has been recently
described also by others (Wood & Warnke, 1982).
Since our first report we have routinely applied
this method for clinical diagnosis and during this
period practical modifications and a further
extension of the reagent range have been
introduced. In this study we describe the standard
procedure as applied to 100 bone marrow biopsies
together with a critical and practical evaluation of
this method in analysing the malignant involvement
of the bone marrow in lymphomas and leukaemias.
Materials and methods
Handling ofbiopsies
Bone marrow trephine biopsies were obtained with
an 11-gauge (4")Jamshidi needle (Cat. No. VRC 4011,
A.R. Horwell Ltd. U.K.) under local anaesthesia
from 5 normal controls and 100 patients
with various haematological diseases. This work
was mainly performed as part of staging procedures
(Table I). Donors of 5-21 years of age served
as normal controls. Two of the 5 normal
samples were obtained from donors for allogeneic
bone marrow transplantation. Three patients had
other indications but proved to have normal bone
marrow architecture. The cores were cut with a
C The Macmillan Press Ltd., 1983
Correspondence: M. Chilosi
Received 16 May 1983; accepted 6 September 1983.764 M. CHILOSI et al.
Table I The diagnosis of the 100 cases
studied for bone marrow histology
Total Cases with apparent
Patients no. BM involvement
Normal 5 none
NHL B-type 56 38 (D:17 N:21)
B-CLL 11 l1(D: 3N: 8)
T-CLL 1 1 (D: 1)
Hodgkin's 20 3 (D: 1 N: 2)
ALL 4 4 (D: 4)
Others 4 1 (D: 1)
D: diffuse N: nodular.
razor blade and two cylinders were obtained. The
first was fixed and embedded in paraffin after
decalcification for conventional histology, whereas
the latter was soaked for 30min-4h at room
temperature in Histocon (Cat. no. 0582,
Polysciences Inc., Warrington, PA., USA), a
medium which gives compactness to the sample.
The biopsy was then placed on a small cork,
covered with O.C.T. (Cat. no. 4583, Raymond
Lamb, London, UK), snap-frozen in liquid nitrogen
and cut at 5-8 pm in a cryostat (Bright). The long
axis of the sample was perpendicular to the knife
edge and the temperature in the microtome
chamber was -25° to -300. The sections were
layered on albumtinized glass slides, serially
numbered and air dried with a cold fan. The
sections could be left at room temperature for as
long as 24h, but were fixed within this period of
time. If the slices were left unfixed for longer than
24h there was some deterioration in quality. For
labelling with monoclonal antibodies a short
fixation (1 min) in cold ethanol (0-4°C) was used,
while unfixed sections gave better results for the
detection of light and heavy chains of Ig. For the
demonstration of enzymes, dipeptidyl (amino)
peptidase IV (DAP IV), alkaline phosphatase
(ALP) and peroxidase (PX) ethanol was used for
5min as a fixative. For non-specific esterase (NSE),
adenosine triphosphatase (ATPase) and
5'nucleotidase (5'Nase) 10% buffered formalin was
optimal (Omin).
Immunofluorescence
The conventional antisera and monoclonal
antibodies used in this study are listed in Table II.
IF and immunoperoxidase (IP) techniques were
used as previously described (Janossy et al., 1980a,
Stein et al., 1980). Briefly, after the rehydration of
sections in buffered saline (10-20min at 20°C) the
sections were covered with diluted antisera (1:20-
1:40) or with monoclonal antibodies (0.1-0.2pg in
10-20p1 fluid), incubated for 30min and washed in
buffered saline (PBS; 10min). When IF was used
antisera raised in goats to human Ig isotypes were
directly conjugated to the fluorochromes fluorescein
isothiocyanate (FITC, green) or tetra-ethyl
rhodamine isothiocyanate (TRITC, red) and
Table II Reagents and their sources
Antisera andantibodies against In Obtainedfrom Ref.
IgM (p chain specific) R Dakopatt
IgD (6 chain specific) R Dakopatt
K (light chain) R Dakopatt
A (light chain) R DakopStt
factor VIII: related antigen R Dakopatt
fibronectin R Dr L. Tfejdosiewicz 1
terminal transferase (TdT) R Prof. F.J. Bollum 2
laminin R Bethesda Res. Lab.
glycophorin M Dr P. Edwards
HLe I (2D1) pan-leucocyte M Dr P. Beverley 3
UCHT1 (T28) OKT3-like pan-T M Dr P. Beverley 4
RFT-1 p 67,000 T+CLL M Royal Free Hospital 5
Leu-I p 67,000 T+CLL M Becton-Dickinson
Leu-2 p 32,000 T suppr/cytotox M Becton-Dickinson
Leu-3 p 55,000 T helper M Becton-Dickinson
RFM1 myeloid (cytoplasmic) M Royal Free Hospital 6
RFD3 follicular dendritic cell M Royal Free Hospital 7
RFB4 cell M Royal Free Hospital 7
HLA-DR M Becton-Dickinson
R: rabbit; M: mouse 1. Trejdosiewicz et al., 1982; 2: Bollum, 1975; 3:
Pizzolo et al., 1980; 4: Beverley & Callard, 1981: 5: Caligaris-Cappio et
al., 1982; 6: Goodall et al., 1983; 7: Bofill et al., 1983.IMMUNOHISTOLOGY OF BONE MARROW 765
simultaneously used in direct IF in various
combinations (e.g. anti-k TRITC/anti-) FITC).
Monoclonal antibodies UCHTI, Leu-2 and anti-
HLA-DR were used in a two-layer sandwich with
goat-anti-mouse-Ig TRITC as a second layer. The
other antibodies were applied in a 3 step indirect IF
so that a rabbit-anti-mouse Ig antiserum (Nordic)
was used as second layer and a goat-anti-rabbit Ig
antiserum conjugated with FITC or TRITC
(Nordic 1:40) as the third layer. Each step was
followed by a quick wash (10min) in buffered
saline (PBS).
For the demonstration of terminal deoxynucleo-
tidyl transferase (TdT) a modification of the
immunofluorescence (IF) method (Thomas et al.,
1982) was introduced. The sections were promptly
fixed in the cryostat chamber for 5min in cold
ethanol (50ml) containing 20 p1 of lM
trichloroacetic acid (TCA).
The sections were then air dryed, incubated with
rabbit anti-TdT serum (1:10 dilution; Bollum,
1975) and washed for 10min. FITC-conjugated
goat anti-rabbit serum (1:40 dilution; Kallested
Ltd.) was used as second layer.
Selected combinations of conventional antisera
and monoclonal antibodies were often used. These
included anti-TdT/anti-HLA-DR, anti-IgM/
UCHT1, anti-TdT/UCHTI. In each combination
monoclonal antibodies were used in two-layer
indirect immunofluorescence where a goat anti-
mouse-Ig-TRITC serum was the second layer. The
conventional reagents were labelled with FITC
(Janossy et al., 1980b).
As we have already pointed out in a technical
note (Chilosi et al., 1983), the IF staining was
compatible with morphological observations. After
having been stained with FITC and/or TRITC
labelled antibodies the sections were re-fixed in
buffered formalin (30min) and stained for 60 sec in
Gill Haematoxylin. The preparations were
examined under a Leitz Dialux microscope or a
Zeiss Standard microscope. The microscopes were
equipped with epifluorescence attachments and
filters for FITC and TRITC. In order to retard
fading of FITC, p-Phenylenediamine (Cat. no.
29500, BDH, Poole, U.K.) was used at 0.1%
concentration in 9:1 mixture of glycerol and PBS
(Johnson et al., 1981).
Immunoperoxidase
For immunohistochemical reactions the endogenous
myeloperoxidase was first inhibited with 0.1%
phenylhydrazine in PBS for 30min (Straus, 1979).
The sections were then incubated with unlabelled
monoclonal antibodies followed by peroxidase
conjugated rabbit-anti-mouse serum which had
been preabsorbed with human Ig (Cat. no. P161
Dakopatt). Rabbit antisera to human Ig isotypes
were followed by swine-anti-rabbit serum and PAP
(Cat. no. Z113 Dakopatt). Following each
incubation the sections were gently washed in PBS
and finally stained for peroxidase using 3'-3-
diaminobenzidine (Graham & Karnovsky, 1966). A
darkening copper sulphate solution was used as
final step before haematoxylin counterstaining
(Hanker et al., 1979).
Enzyme histochemistry
A panel of enzymes was detected on sections
obtained as described above in all cases using the
methods previously described (Chilosi et al., 1981,
1982a, 1982b). The enzymes and the cells positively
characterized by these stainings are listed in Table
III.
A detailed immunohistological analysis with the
Table III Enzyme histochemical reactions on bone
marrow
Abbr. Enzyme Reagents Markerfrom Ref.
PX Peroxidase DAB, H202 myeloid cells 1




NSE Non- Naphthyl- monocytes I
specific acetate and
esterase HPR macrophages








ATPase ATP, B-lympho- I
lead cytes
nitrate




DAP Dipeptidyl- gly-pro- T lympho- 2
IV amino methoxy cytes
pepti- naphthyl- sinus
dase IV amide lining cells
Fast
Blue BB.
°HPR: hexazotized pararosaniline; HNF: hexazotized
new fuchsine; References: 1: Chilosi et al., 1982b; 2:
Chilosi et al., 1982a.766 M. CHILOSI et al.
whole panel of reagents was performed on the 5
normal samples and in 57 samples in which a
localization of neoplasia was evident when morpho-
logically analysed on haematoxylin and
endogenous-peroxidase stained sections. The
remaining 38 non-involved samples were only
studied on sections stained for enzyme histo-
chemistry (Px, NSE, etc.).
Results
Assessment ofcryostat sectionsfrom bone marrow
Bone marrow samples were more difficult to cut in
the cryostat than other tissues such as lymph node,
thymus or other parenchymal organs. Without any
supportive fixative the loosely packed haemopoietic
tissue frequently collapsed onto the bone
trabeculae, particularly when taken from aged
patients with abundant fatty tissue. In our hands
the commercially available medium, Histocon(R),
gave the best results when used for "soaking" the
core of the bone marrow biopsy. Other media we
used previously such as gum-sucrose solution
(Chilosi et al., 1982b) or polyacrylamide were also
advantageous when compared to the unprepared
biopsies but were distinctly inferior, in terms of
preservation of the contacts between the bone
trabeculae and soft tissue as well as details of
cellular features, than the samples soaked in
Histocon. We also noted that samples would be left
in Histocon up to 24h at room temperature with
no apparent deterioration in terms of
histomorphology.
Figure 1 Cryostat section of the bone marrow from a
patient with non-Hodgkin's lymphoma. The section is
stained for endogenous myeloperoxidase and
haematoxylin. The lymphoid cells form a large nodule
and also infiltrate the marrow to a variable degree.
During this study a two-stage evaluation was
adopted: Samples were processed as rapidly as
possible through cryostat sectioning and staining
for haematoxylin and endogenous myeloperoxidase
(Figure 1). On the basis of the first assessment,
within 2-3h of biopsy, the specific antibody and
enzyme investigation was planned.
In acute leukaemias the infiltration was diffuse,
while in most cases of lymphoma and B-CLL
lymphoid nodules were seen (Figure 1). All
immunological markers were successfully
demonstrated on cryostat sections of bone marrow
and could be viewed together with haematoxylin
counterstain (Figure 2). The IF staining was
particularly informative when antibodies were
conjugated to different fluorochromes and used in
combinations. This double staining was useful to
establish B cell monoclonality in the neoplastic
nodules (using anti-K and anti-i) combinations to
reveal the relationships between different cell
populations, e.g. during the investigation of T cell
"contamination" within the nodules of malignant B
lymphocytes. This was studied using anti-IgM and
anti-T cell antibodies.
Normal bone marrow
The haemopoietic tissue in normal samples was, as
expected, mainly composed of peroxidase positive
granulocytic cells in various stages of maturation.
Many peroxidase-negative erythroid cells could be
also seen among the myeloid population. These
were scattered or were seen in small clusters. These
erythrocyte precursors could also be positively
stained on consecutive sections with anti-
":
Figure 2 Cryostat section of the bone marrow from a
patient with B-CLL. The cells are stained for
Haematoxylin (normal light ) and for RFA-1 (TI-like
antigen; MW 67k) with TRITC labelled second layer
(red fluorescence). The staining is heterogeneous: 90%
of the cells are moderately strongly RFA-l+ (CLL
cells) while 10% of cells are strongly RFA-l + (T cells;
see also Figures 5 and 6).IMMUNOHISTOLOGY OF BONE MARROW 767
glycophorin serum. Megakaryocytes were present in
all five samples and a strong immunostaining for
factor VIII was invariably demonstrated in these
cells. The stromal fibroblastic cells, visualized by
their strong alkaline phosphatase reactivity (Westen
& Bainton, 1979), appeared as a network which
was even better visualized by staining for fibro-
nectin with a rabbit antibody. Laminin could also
be demonstrated by anti-laminin antibody around
the blood vessels and the fat cells. Other vascular
structures such as bone marrow sinuses were
stained neither by anti-fibronectin or by anti-
laminin antibodies.
After having established the stromal network of
the normal bone marrow, attention was focussed
on the lympho-haemopoietic elements. Using anti-
TdT serum a few scattered cells with clear nuclear
staining could be identified. They were usually
similar to small lymphoid cells (Figure 3) but were
negative for immunoglobulin and T lymphoid
antigens. Int&estingly, only about half of these
TdT+ cells were HLA-DR positive (relatively
weakly; Figure 3) but all TdT+ cells failed to label
with the monoclonal antibody (J-5) reacting with
common ALL antigen.
Combining anti-fibronectin with anti-myeloid
(RFM-1) antibodies, differentiating myeloid cells
appeared to be mainly in the vicinity of the fibro-
nectin positive reticular network. In contrast,
erythroid precursors (glycophorin positive) were
usually found in separate clusters. We have also
attempted to use a monoclonal antibody, RFB-1
(Bodger et al., 1981) which reacts with lympho-
haemopoietic precursor cells including TdT+
lymphoid precursors and myeloid precursors such
as CFUc and erythroid burst forming units
(BUFe). Unfortunately, the RFB-1 apparently fails
to stain sections of normal bone marrow and
therefore no selective marker for early haemopoietic
cells was used in this investigation. Anti-HLA-DR,
although clearly reactive with 50% of TdT+
precursors and with larger cells of myeloblast
morphology (Figure 3), was not a suitable marker
for precursor cells because many macrophages and
endothelial cells were also HLA-DR+.
The study of T lymphocyte subsets in normal
bone marrow showed a scattered population with
the dominance of T cells (3:1) expressing the
suppressor/cytotoxic (Leu-2+) phenotype. The same
phenomenon has previously been demonstrated on
cells suspension (Janossy et al., 1981). The higher
background IF staining for endogenous Ig in the
normal marrow made it difficult to demonstrate
individual B cells with various antisera to surface
Ig. Preliminary findings show that these B cells can
be observed with recently developed B cell specific
monoclonal antibodies (e.g. RFB-4 reagent).
Finally, the acid phosphatase and non-specific
esterase staining has identified an array of
monocytic cells amongst the myeloid cells. None of
these cells were, however, of follicular dendritic
(FD) type because RFD-3 (an antibody specific for
FD in the normal germinal centre) identified no
positive cells in the normal bone marrow (see
pathological samples below).
Pathological cases: non Hodgkin's lymphoma (NHL)
During the course of this study 38 samples of bone
marrow showed lymphomatous involvement. Most
of these had also been studied on lymph node
cryostat sections before the bone marrow biopsy
was taken, thus the immunological and histo-
chemical phenotypes of neoplastic cells could be
compared in the nodes and in the bone marrow. In
6 cases however the only available neoplastic tissue
was the bone marrow; no enlarged lymph nodes
could be found, or these nodes were located at
anatomical sites inaccessible for biopsy while the
peripheral blood showed no leukaemic involvement.
In these 6 cases the bone marrow biopsy was
diagnostic and the full immunohistological analysis
could be performed on the frozen material.
Furthermore, in additional 6 cases the paraffin
embedded bone marrow biopsy did not give a
definite answer in respect of staging. In these cases
the monoclonality of light chain expression
established the neoplastic nature of bone marrow
involvement.
All NHL cases examined were of B-type and
strongly expressed HLe-I (2D1) and HLA-DR (Ta)
antigen (Pizzolo et al., 1980). Labelling of surface
Ig and the clonal restriction of the light chain could
be usually demonstrated in NHL cases, but the
density of Ig expression was variable in the
different patients. It was sometimes difficult to
demonstrate the monoclonality of K/2 expression in
cases of follicular lymphomas because of the
background. An interesting finding was that in
three marrow samples studied the antibody to
follicular dendritic cells (RDF-3) strongly reacted
with cells of stellate appearance. A further case of
mantle zone lymphoma also showed germinal
centres in the BM with a ', 6-, ,K+, i- B cell
component. These monoclonal B cells were found
around agerminal centrewhichhad strongly RFD-3+
dendritic cells in the middle of the nodule
(Figure 4). As expected, in these cases of NHL the
majority of cells were unreactive with T cell-specific
antibodies such as UCHTI (detecting OKT3 like
antigen) or Leu-2 and Leu-3 (detecting OKT8 and
OKT4 antigen, respectively). Nevertheless, a
variable but generally conspicuous number of
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cells) were seen scattered amongst the malignant B
cell population.
In 21 cases the activity of the enzyme ATPase
could be demonstrated in neoplastic B lymphocytes
as also observed in the corresponding lymph nodes
affected by lymphoma. The ATPase reactivity was
particularly evident and constant in the cases with
lympho-plasmacytic differentiation.
Peroxidase, DAP-IV, NSE and 5'nucleotidase
were negative in the neoplastic cells of all cases. In
two cases the proliferating cells exhibited alkaline
phosphatase reactivity as found in rare cases of
B-NHL (Poppema et al., 1981).
Bone marrow involvement in chronic lymphoid
leukaemia (CLL)
Eleven cases of chronic lymphocytic leukaemia were
analyzed (10 B-CLL and one T-CLL). In all cases
of B-CLL HLA-DR antigens, surface Ig and light
chain monoclonality could be demonstrated (Figure
5). In these marrow samples a clear positive
staining for a T cell associated antigen (67K;
detected by RFT-1, as well as Leu-l or OKTI
monoclonal antibodies) could be obtained on the
malignant IgM+ B cell population (Figure 2)
confirming previous observation on cell suspension
(Royston et al., 1980; Martin et al., 1981). In most
cases of B-CLL, in addition to B cells, large
numbers (10-30%) of infiltrating T lymphocytes
were seen. These were scattered among neoplastic
cells (Figure 6) and were dominantly Leu-3+, Leu-2-
while the circulating T lymphocyte in the blood
contained many (50-70%) Leu-2+, Leu-3-
suppressor/cytotoxic type T cells.
One case of CLL was however of T cell origin,
expressing both the immuno- and enzyme-histo-
chemical markers of inducer-type T lymphocytes
(Leu-I+, Leu-3+ and DAP-IV enzyme positivity).
Finally, in one patient the diagnosis of hairy cell
leukaemia (HCL) was confirmed on the bone
marrow trephine. The patient had leucopenia with
only a few suspicious lymphoid cells. At the
aspiration of the marrow, the "tap" was dry. The
sections, however, revealed a diffuse infiltrate of
cells strongly positive for tartrate resistant acid
phosphatase (TRAP) and reactive with the B cell
Ab RFB-4. These cells were peroxidase and RFT-1
negative. In this particular case theTRAP', RFB-4+
phenotype established the diagnosis because the
IgM, K and A labelling was uninterpretable due to
high background staining. It is interesting to note
that the follicular dendritic cells were apparently
absent in cases of CLL and HCL since no RFD-3+
cells could be detected in these samples.
Hodgkin's disease
Bone marrow cryostat sections were studied in 20
cases of HD. Bone marrow involvement was
observed in three. The neoplastic nodules in these
patients were characterized by a heterogenous cell
population (Figure 7) that was also seen in the
affected lymph nodes of the same patients. Large
numbers of macrophages (NSE positive) and T
lymphocytes (UCHT1 positive) were the
predominant cells together with a few fibroblastic
elements, B cells and large Hodgkin and Reed-
Stemnberg cells. These latter cells were negative for
all markers tested with the exception of HLA-DR.
The T lymphocytes were, again, mainly of the
Figure 5 Monoclonality testing of bone marrow Figure 6 The same case as in Figure 5 is stained for involvement in a case of B-CLL (K: green, FITC; A: IgM (p specific; green, FITC) and for T cells (UCHTI; red, TRITC). The vast majority of cells are K+, A- red, TRITC). Approximately 10-15% of lymphoid (green) with weak to moderate staining intensity. Only cells are of T type; these correspond to the strongly one cell is strongly A', K- (red). RFA-1 + cells in Figure 2.IMMUNOHISTOLOGY OF BONE MARROW 771 mg^;-}i ;
Figure 7 Cryostat sections of the bone marrow from Figure 8 Double staining of a bone marrow with
a patient with Hodgkin's disease. In the upper panel anti-TdT (green; FITC) and anti-HLA-DR (red;
the section is stained for endogenous myeloperoxidase TRITC). The sample contains many blast cells that are
and haematoxylin. Large Reed-Sternberg cells are TdT+, HLA-DR+ (common acute lymphoblastic
clearly visible. The lymphocytes as shown in the lower leukaemia). The HLA-DR+ expression on these blasts
panel, are predominantly T cells (UCHTI, immuno- appears to be stronger than on the normal TdT+ cells
peroxidase staining). shown in Figure 3. Similarly, these leukaemic blasts are
J-5 positive (not shown).
inducer type (Leu-3+, Leu-2 ). The same Leu-3/
Leu-2 ratio was demonstrable in lymph nodes of
the same patients.
Acute lymphoblastic leukaemia (ALL)
Four cases of lymphoblastic leukaemia of the non-B,
non-T type were investigated. The neoplastic
cells were strongly HLA-DR positive and lacked B
and T cell markers. In one case the peripheral
blood was free of blasts and bone marrow
aspiration was also unsuccessful. Nevertheless, in
cryostat sections of the bone marrow biopsy
neoplastic cells could be clearly identified in the
haematoxylin preparation. The diagnosis was then
proven by staining the blast cells with anti-TdT
serum and anti-HLA-DR (Figure 8). After ethanol-
TCA fixation 40-50% of cells exhibited a strong
nuclear reactivity. The 3 other cases were also
TdT+. In one of these J-5 antibody was tested and
showed clear strong reactivity with the common
ALL antigen on the blast cells. Interestingly,
however, the normal TdT+ cells could not be
visualized by the J-5 antibody. The expression of
common ALL antigen on normal lymphoid
precursors is known to be weaker than on
malignant ALL blast cells (Janossy et al., 1979).
Finally, a potentially confusing observation was
resolved by double marker studies. In one biopsy
the reactivity with HLA-DR and TdT in 60% of
blast cells indicated common ALL but large
proportions of cells (30-35%) were UCHT1
positive. When used in double combination, these




Our observations confirm previous reports (Pizzolo
et al., 1982; Chilosi et al., 1982a,b; Wood &
Warnke, 1982) that the immunohistochemical
analysis of frozen bone marrow biopsies is
applicable as a routine procedure. The aim of
lymphoma diagnosis is acceptable morphology with
only minimal destruction of tissue antigens and
enzymes (Stein et al., 1980; Mason & Biberfeld,
1980; Poppema et al., 1982; Chilosi et al., 1981,
1982b). Here we have followed this aim and the
reproducibility of bone marrow analysis has been
ascertained by further minor technical advances.
These are "soaking" of bone marrow biopsies in
Histocon (in order to give compactness to the
sample) and fixing the sections onto the slides with
albumin or prolonged drying and only
minimal additional fixation. We have found that
the exact method of fixation is different for
antibodies and enzymes. For example, the labelling
of TdT molecules in the nucleus requires a quick
fixation within the cryostat. This is necessary to
prevent the diffusion of this soluble protein from
the nucleus into the cytoplasm. Other enzymes also
need short incubation with cold ethanol or buffered
formalin for optimum performance (see Materials
and methods) but antibodies to "structural"
membrane antigens can be optimally detected even
without additional fixative. On the other hand,
acetone and chloroform are not recommended
because these lipid solvents increase background
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monoclonal antibodies of high quality (mostly
culture supernatants) were used (Figures 1-3 and
7).
As a result of these technical steps the immuno-
histochemical diagnosis could be reached in
virtually all pathological samples. Notably, amongst
the hundred patients analysed, 6 received their
diagnosis exclusively from the bone marrow studies
because a final conclusion could not be reached by
other methods. In another 6 cases the information
about staging the disease (i.e. demonstration of the
monoclonality of the B cells) was superior in the
frozen biopsies to that seen in the paraffin
embedded preparations.
An additional advantage is the speed with which
these results are obtained. The diagnosis is available
in a few hours and usually waits days until the
confirmation arrives from the routinely processed
decalcified, paraffin embedded or plastic embedded
material. This new technology is therefore a useful
addition to histopathology.
Immunofluorescence and immunohistochemistry
In our study immunofluorescence (IF) and immuno-
peroxidase (IP) have been used. The advantage of
immunofluorescence is that this is a rapid method
which is easy to standardize. When used with p-
phenylenediamine the fading is slow and the
morphology is shown by counterstaining with
Haematoxylin (Figure 2; Chilosi et al., 1983). The
further advantage is the use of FITC and TRITC
labelled antibodies in pairs with selective green and
red filters. This is the only reliable method for
investigating double labelled cells since it is difficult
to assess fine gradations of transitional colours
between the brown, red and blue dyes in double
immunohistochemical assays (reviewed by Mason et
al., 1982). The investigations of KIA expression
(monoclonality tests), cell-cell interactions and the
expression of different antigens by the same cell
type require the IF approach. Antibodies
conjugated to the recently developed red
fluorochrome phyco-erythrin (PE; Oi et al., 1982)
can even be used as a direct single layer in
combination with FITC labelled antibody (Pizzolo
et al., 1983 ). This progress will lead to the use of
the same reagents in histology and cell suspensions:
FITC-PE combinations are ideally suited for double
fluorescence cell sorting with a single laser on cell
sorters. In this way the analysis of microenviron-
mental distribution of various cell types following
their functional assessment in vitro can be achieved.
In contrast, the advantage of IP and the recently
developed immuno-alkaline phosphatase (IAP)
method (Falini et al., personal communication,
1983) is that the morphology and the permanent
immuno-staining of the tissues can be viewed with a
light microscope without changing the position of
filters. In the bone marrow the IAP staining is
better than IP because so far no suitable method
could be found which blocks endogenous
peroxidase in strongly positive cells (e.g.
eosinophils) without denaturing membrane
antigens. Nevertheless, this is not a practical
problem since these strongly staining cells are
usually few and easily recognized (Wood &
Warnke, 1982).
Clinical applications
These results have been achieved by selecting a
limited range of reagents, many of which are
already commercially available (Table I).
Antibodies to non-immunoglobulin membrane
antigens on B lymphocytes (e.g. RFB-4 or Tol5 by
Stein et al., 1982), to follicular dendritic
cells (RFD-3 or R4/23 by Stein et al., 1982) as well
as additional selective reagents against bone
marrow precursor cells are essential. A typical
example is the use of anti-B reagent (together with
the TRAP enzyme) for the characterizing bone
marrow sections in hairy cell leukaemia. An
interesting further observation is that with the
existing reagents the immuno-diagnosis of different
B cell malignancies have begun. A T cell associated
marker, p67, is expressed moderately strongly on
suspensions of B-CLL cells (Royston et al., 1980;
Martin et al., 1981). Now we are able to show that
the same p67 antigen is present in the lymphoid
nodules of B-CLL (Figure 2) but not in other B cell
malignancies of the bone marrow. This indicates
that antibodies distinguish between prognostically
different groups (reviewed by Stein et al., 1982).
Furthermore, with the existing reagents it was
possible to analyse bone marrow involvement in
centroblastic/centrocytic (follicular) lymphoma. The
RFD-3 antibody has detected follicular dendritic
cells in the peritrabecular areas, while RFD-3+ cells
are totally absent in the normal bone marrow. This
observation confirms the report by Gerdes et al.,
(1982) who described that follicular dendritic cells
(detected by R4/23) were present in the involved
tissues of patients with centroblastic/centrocytic
lymphoma.
Finally, the observations have helped to clarify
the microenvironmental relationship between
different cell types in the bone marrow. First, we
have found that differentiating erythroid and
myeloid cells clearly occupy different niches. The
latter are closer to the fibronectin positive network
of the normal marrow. There is evidence of the
permissive role of fibroblast-like cells in
haemopoiesis (Weiss, 1981) and fibronectin positive
cells are important to stem cell growth in vitro
(Castro-Malspina et al., 1980; Reincke et al., 1982).774 M. CHILOSI et al.
Our results of compartmentalization of myeloid and
erythroid precursors confirm the histochemical
studies of Western & Bainton (1979). The TdT+
lymphoid precursors appear to be scattered in the
marrow and are not restricted only to the peritra-
becular areas (Figure 3). Further investigations are
needed to find the accessory cells with which TdT+
cells form functional relationships.
Second, we have found very large numbers of
T4+ T cells of helper type in the marrow nodules
of B-CLL (Figure 6). Similar findings have also
been observed in the peripheral nodes (Pizzolo et
al., 1983a) but these observations contrast with the
observations in the circulating blood of patients
with B-CLL where frequently the T4+ cells are
present in low percentage and in a minority
(Platsoucas et al., 1982). These findings show that
the observations on blood samples are not
representative of those in the lymphoid nodules
(including bone marrow) and raise the following
possibility. The T4+ cells seen in situ may
contribute to the expansion of the malignant clone
("helper" effect) while elsewhere in the body T cells
of suppressor type may cause secondary immuno-
deficiency (Pizzolo et al., 1983 ).
In conclusion, the immuno- and histo-chemical
investigation of frozen biopsies of bone marrow
provide diagnostic as well as basic information
about malignancy. The range of reagents (Table I)
complemented with the antibodies against Reed-
Sternberg cells (Schwab et al., 1982) and to
activated and dividing cell populations (Gerdes et
al., 1982) are likely to become indispensable for the
precise diagnosis of marrow involvement.
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